Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
Gabrielle Sarlon, Head of the Department of Vascular Medicine and Hypertension at APHM (La Timone and Nord Hospitals), shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Taboo subject: heavy periods for women on oral anticoagulants! !️
The GENB-OAC study is published in the RPTH Journal!
Key messages to improve the management of venous thromboembolic disease in women of childbearing age:
- Heavy menstruation is common in the general population (30-50% of women!!) and is responsible for iron deficiency (nearly 50% of women!!)
- This problem is taboo and underdiagnosed
- Oral anticoagulants increase the abundance of menstruation and alter the quality of life of women of childbearing age.
- Apixaban causes less genital bleeding than rivaroxaban and VKA, which opens up a therapeutic avenue for this problem
- Heavy menstruation must be systematically sought before starting anticoagulants and treatment and follow-up must be adapted accordingly, in particular with multidisciplinary care
For the GENB-OAC team, this study represents:
- 9 years of hard work
- 10 expert thrombosis centers involved
- 445 French cars included
A huge M E R C I to all, and in the hope that these results will help to shed light on this problem and better care!
And special dedication to Professor Morange Pierre, my friend, without whom the study would not have seen the light of day.”
Title: Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC Study
Authors: Gabrielle Sarlon-Bartoli, Barbara Leclercq, Nathalie Trillot, Isabelle Mahé, Marie Daoud-Elias, Andrea Buchmuller, Geraldine Poenou, Antoine Elias, Jean Noel Poggi, Francis Couturaud, Noemie Resseguier, Martin Postzich, Lylia Hammoudi, Yasmine Benredouane, Florence Bretelle, Louisa Goumidi, Pierre Suchon, Sarah Jidal, Antonia Perez-Martin, Clementine Rousselin, Isabelle Quere, Sandrine Mestre, Marie Antoinette Sevestre, Simon Soudet, Laurent Bertoletti, Sophie Susen, Pierre Emmanuel Morange
Read the Full Article on RPTH Journal.

Stay updated with Hemostasis Today.
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD
-
Sep 10, 2026, 21:31Alejandro González Veliz: Pregnancy is a Cardiovascular Stress Test
-
Sep 10, 2026, 21:30Tareq Abadl: Did You Know That the Type of Hemoglobin in Our Blood Changes Throughout Life?
-
Sep 10, 2026, 21:30Sumyea Kabir: Apheresis Awareness Day – One Donor, One Procedure, One Therapeutic Difference
-
Sep 10, 2026, 21:30Suhasini Sil: Excited to Share Our New Publication on HLA Beyond Histocompatibility
-
Sep 10, 2026, 21:29Michael Meneghini: Your Calves Are Not Just for Walking
-
Sep 10, 2026, 21:27One month until International Plasma Awareness Week – PPTA Europe
-
Sep 10, 2026, 21:26John Strouse: Supporting Research to Improve Lives in Sickle Cell Disease